MAS Advisory Global Pharma Project

active

This project aims to provide services to pharmaceutical manufacturers and distributors – mostly generics or OTC producers, but also Active Pharmaceutical Ingredients (API) and Bulk Process Intermediates (BPI) producers, and vertically integrated companies. The offering is structured in modules to address client specific needs. The modular approach encompasses broader REF/climate/sustainability, material-energy-water efficiency/productivity, and response to climate change. Offering to the individual client will consist of one or more modules, depending on client needs. In terms of GHG emissions, primary focus is on GHG emissions from own activities (Scope 1 and Scope 2) including operations on production sites, and - if owned - also the distribution chain and respective upstream activities. The supplementary knowledge creation and sharing is intended to support activities which would allow for increased uptake of best practices and resource efficiency measures/tools that can deliver benefits beyond the firms supported directly. This will be done through the creation of knowledge materials and dissemination through awareness raising events.